A type III hybrid effectiveness–implementation trial compared community-based organization versus direct-to-consumer delivery of the Keep It Up! digital HIV prevention intervention for young men who have...
A large cross-sectional Italian study evaluated the prevalence of cognitive frailty and identified HIV-specific and clinical risk factors among adults 50 years or older living with HIV, highlighting the...
In a large multicountry trial, researchers evaluated whether an integrase inhibitor–based regimen offers comparable or superior treatment outcomes to a boosted protease inhibitor regimen in adults with...
A national analysis presented at the 2025 AHA Scientific Sessions found that patients with HIV hospitalized with cardiac implantable electronic device–related infective endocarditis had significantly lower...
A new longitudinal study published in the Journal of the American Academy of Dermatology evaluated more than a decade of data from adults living with HIV, revealing a steady decline in dermatologic disease...
Managing HIV today means balancing speed, precision, and prevention. From deciding when to start antiretroviral therapy (ART) to optimizing follow-up labs and ensuring vaccine and prophylaxis coverage,...
Results from a phase 2B randomized, double-blind, placebo-controlled trial suggest that semaglutide not only reduces inflammation and adiposity in people with HIV but may also provide a neurocognitive...
In a recent multicenter retrospective case series, isotretinoin was effective in treating acne among transgender and gender-diverse individuals undergoing masculinizing hormone therapy, with significantly...
Sexual and gender minority (SGM) populations face significantly higher odds of being diagnosed with multiple mental health conditions compared with their cisgender heterosexual counterparts, according to a...
